Rifaximin Therapy of Irritable Bowel Syndrome
نویسندگان
چکیده
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain and altered bowel habits in the absence of specific organic pathology. Although the underlying pathogenesis of IBS is not well-understood, small intestinal bacterial overgrowth (SIBO) or other abnormalities in the gut flora is believed to contribute to the development of a subset of IBS cases. Rifaximin is a poorly absorbed antimicrobial with activity against enteric pathogens. A number of studies have shown a significant improvement in IBS symptoms with antibiotic therapy including rifaximin. In this review, we discuss the pharmacokinetics, in vitro susceptibility profile, and efficacy and safety data from clinical trials of rifaximin treatment of IBS.
منابع مشابه
The effectiveness of of cognitive-behavioral therapy on the general health and quality of life of patients with irritable bowel syndrome
Background: One of the challenges of patients with irritable bowel syndrome is to reduce the quality of life and general health of patients. In the last decade, cognitive-behavioral therapy has been introduced as one of the effective treatments for many disorders. The purpose of this study was to determine the effectiveness of cognitive-behavioral therapy on the general health and quality of li...
متن کاملTreatment of Bacterial Overgrowth in Patients With Irritable Bowel Syndrome
Background: Rifaximin is an effective treatment of irritable bowel syndrome (IBS) with small intestinal bacterial overgrowth (SIBO), yet long-term management has not been well studied. Patients with functional bowel symptoms were characterized by lactulose breath test (LBT), and a comprehensive approach to long-term SIBO therapy was employed. Methods: On day 0, eligible patients completed a bas...
متن کاملComparing the mental health of patients with irritable bowel syndrome and healthy subjects in Rasht (Iran), 2014-2015
Background and Objective: Irritable bowel syndrome is one of the most common functional gastrointestinal disorders in which psychological factors play an important role in developing and exacerbating the symptoms. The aim of current study was comparing mental health of patients with irritable bowel syndrome with normal individuals alongside the role of mental health predicting high risk of irri...
متن کاملRifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
BACKGROUND While rifaximin was able to improve symptoms in patients with irritable bowel syndrome (IBS) in phase III trials, these results are yet to be repeated in phase IV studies. AIM To evaluate the treatment response to rifaximin in IBS patients in a phase IV trial. METHODS IBS patients underwent lactulose hydrogen breath testing (LHBT). LHBT-positive patients were treated with rifaxim...
متن کاملThe Effects of Cognitive – Behavior Therapy and Drug Therapy on Quality of Life and Symptoms of Patients with Irritable Bowel Syndrome
Background & Aims: Psychological treatment and the efficacy of drug therapy are considered to be useful in quality of life and symptoms of patients with irritable bowel syndrome. The aim of this study was to examine the effects of cognitive-behavior therapy associated with drug therapy in comparison to drug therapy alone on the quality of life and symptoms of IBS patients with diarrhea predomin...
متن کامل